{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T22:51:02Z","timestamp":1792018262980,"version":"4.4.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,20]],"date-time":"2023-12-20T00:00:00Z","timestamp":1703030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,12,20]],"date-time":"2023-12-20T00:00:00Z","timestamp":1703030400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["20H00542"],"award-info":[{"award-number":["20H00542"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22H03157"],"award-info":[{"award-number":["22H03157"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Heart failure (HF) is a major cause of death worldwide. The most effective treatment for HF is heart transplantation, but its use is limited by the scarcity of donor hearts. Recently, stem cell-based therapy has emerged as a promising approach for treating myocardial infarction. Our research group has been investigating the use of human induced pluripotent stem cell-derived cardiomyocyte patches as a potential therapeutic candidate. We have successfully conducted eight cases of clinical trials and demonstrated the safety and effectiveness of this approach. However, further advancements are necessary to overcome immune rejection and enhance therapeutic efficacy. In this study, we propose a novel and efficient technique for constructing mesenchymal stem cell (MSC) tissue sheets, which can be transplanted effectively for treating myocardial infarction repair.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We applied a one-step method to construct the human adipose-derived mesenchymal stem cell (hADSC) tissue sheet on a poly(lactic-co-glycolic acid) fiber scaffold. Histology, immunofluorescence, and paracrine profile assessment were used to determine the organization and function of the hADSC tissue sheet. Echocardiography and pathological analyses of heart sections were performed to evaluate cardiac function, fibrosis area, angiogenesis, and left ventricular remodeling.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In vitro, the hADSC tissue sheet showed great organization, abundant ECM expression, and increased paracrine secretion than single cells. In vivo, the hADSC tissue sheet group demonstrated improved cardiac functional recovery, less ventricular remodeling, decreased fibrosis, and enhanced angiogenesis than the MI group.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>We developed thick and functional hADSC tissue sheets via the one-step strategy. The hADSC tissue sheet showed excellent performance in treating myocardial infarction in the rat model.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Graphical Abstract<\/jats:title>\n                \n              <\/jats:sec>","DOI":"10.1186\/s13287-023-03560-9","type":"journal-article","created":{"date-parts":[[2023,12,20]],"date-time":"2023-12-20T16:03:29Z","timestamp":1703088209000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Development of a thick and functional human adipose-derived stem cell tissue sheet for myocardial infarction repair in rat hearts"],"prefix":"10.1186","volume":"14","author":[{"given":"Jingbo","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akima","family":"Harada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masako","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Tabata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lifu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0808-5072","authenticated-orcid":false,"given":"Li","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeru","family":"Miyagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,20]]},"reference":[{"key":"3560_CR1","doi-asserted-by":"publisher","first-page":"e254","DOI":"10.1161\/CIR.0000000000000950","volume":"143","author":"SS Virani","year":"2021","unstructured":"Virani SS, Alonso A, Aparicio HJ, Benjamin EJ, Bittencourt MS, Callaway CW, et al. Heart disease and stroke statistics-2021 update: a report from the American Heart Association. Circulation. 2021;143:e254-743.","journal-title":"Circulation"},{"key":"3560_CR2","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41569-018-0119-4","volume":"16","author":"D Zhao","year":"2019","unstructured":"Zhao D, Liu J, Wang M, Zhang X, Zhou M. Epidemiology of cardiovascular disease in China: current features and implications. Nat Rev Cardiol. 2019;16:203\u201312.","journal-title":"Nat Rev Cardiol"},{"key":"3560_CR3","doi-asserted-by":"publisher","first-page":"407","DOI":"10.4330\/wjc.v9.i5.407","volume":"9","author":"TJ Cahill","year":"2017","unstructured":"Cahill TJ, Kharbanda RK. Heart failure after myocardial infarction in the era of primary percutaneous coronary intervention: Mechanisms, incidence and identification of patients at risk. World J Cardiol. 2017;9:407\u201315.","journal-title":"World J Cardiol"},{"key":"3560_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2011.130","volume":"2","author":"M Chiong","year":"2011","unstructured":"Chiong M, Wang ZV, Pedrozo Z, Cao DJ, Troncoso R, Ibacache M, et al. Cardiomyocyte death: mechanisms and translational implications. Cell Death Dis. 2011;2: e244.","journal-title":"Cell Death Dis"},{"key":"3560_CR5","first-page":"2999","volume":"6","author":"R Guo","year":"2021","unstructured":"Guo R, Wan F, Morimatsu M, Xu Q, Feng T, Yang H, et al. Cell sheet formation enhances the therapeutic effects of human umbilical cord mesenchymal stem cells on myocardial infarction as a bioactive material. Bioact Mater. 2021;6:2999\u20133012.","journal-title":"Bioact Mater"},{"key":"3560_CR6","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1253\/circj.CJ-17-0162","volume":"81","author":"H-Y Lee","year":"2017","unstructured":"Lee H-Y, Oh B-H. Heart transplantation in Asia. Circ J. 2017;81:617\u201321.","journal-title":"Circ J"},{"key":"3560_CR7","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1002\/stem.2778","volume":"36","author":"R Wu","year":"2018","unstructured":"Wu R, Hu X, Wang J. Concise review: optimized strategies for stem cell-based therapy in myocardial repair: clinical translatability and potential limitation. Stem Cells. 2018;36:482\u2013500.","journal-title":"Stem Cells"},{"key":"3560_CR8","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202200431","volume":"9","author":"Y Xia","year":"2022","unstructured":"Xia Y, Xu X, Guo Y, Lin C, Xu X, Zhang F, et al. Mesenchymal stromal cells overexpressing farnesoid x receptor exert cardioprotective effects against acute ischemic heart injury by binding endogenous bile acids. Adv Sci (Weinh). 2022;9: e2200431.","journal-title":"Adv Sci (Weinh)"},{"key":"3560_CR9","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s13287-017-0585-3","volume":"8","author":"T Ma","year":"2017","unstructured":"Ma T, Sun J, Zhao Z, Lei W, Chen Y, Wang X, et al. A brief review: adipose-derived stem cells and their therapeutic potential in cardiovascular diseases. Stem Cell Res Ther. 2017;8:124.","journal-title":"Stem Cell Res Ther"},{"key":"3560_CR10","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1186\/s13287-022-02919-8","volume":"13","author":"S Gao","year":"2022","unstructured":"Gao S, Jin Y, Ma J, Wang J, Wang J, Shao Z, et al. Preclinical study of human umbilical cord mesenchymal stem cell sheets for the recovery of ischemic heart tissue. Stem Cell Res Ther. 2022;13:252.","journal-title":"Stem Cell Res Ther"},{"key":"3560_CR11","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/j.nucmedbio.2011.03.008","volume":"38","author":"A Gholamrezanezhad","year":"2011","unstructured":"Gholamrezanezhad A, Mirpour S, Bagheri M, Mohamadnejad M, Alimoghaddam K, Abdolahzadeh L, et al. In vivo tracking of 111In-oxine labeled mesenchymal stem cells following infusion in patients with advanced cirrhosis. Nucl Med Biol. 2011;38:961\u20137.","journal-title":"Nucl Med Biol"},{"key":"3560_CR12","doi-asserted-by":"publisher","first-page":"333","DOI":"10.3348\/kjr.2018.0280","volume":"20","author":"SM Ko","year":"2019","unstructured":"Ko SM, Kim TH, Chun EJ, Kim JY, Hwang SH. Assessment of left ventricular myocardial diseases with cardiac computed tomography. Korean J Radiol. 2019;20:333.","journal-title":"Korean J Radiol"},{"key":"3560_CR13","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/s41529-022-00277-7","volume":"6","author":"A Samir","year":"2022","unstructured":"Samir A, Ashour FH, Hakim AAA, Bassyouni M. Recent advances in biodegradable polymers for sustainable applications. npj Mater Degrad. 2022;6:68.","journal-title":"npj Mater Degrad"},{"key":"3560_CR14","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1080\/15583724.2017.1332640","volume":"58","author":"F Hajiali","year":"2018","unstructured":"Hajiali F, Tajbakhsh S, Shojaei A. Fabrication and properties of polycaprolactone composites containing calcium phosphate-based ceramics and bioactive glasses in bone tissue engineering: a review. Polym Rev. 2018;58:164\u2013207.","journal-title":"Polym Rev"},{"key":"3560_CR15","doi-asserted-by":"publisher","DOI":"10.1002\/9780470649848","volume-title":"Poly(lactic acid): synthesis, structures, properties, processing, and applications","year":"2010","unstructured":"Auras R, Lim L-T, Selke SEM, Tsuji H, editors. Poly(lactic acid): synthesis, structures, properties, processing, and applications. Hoboken: Wiley; 2010. https:\/\/doi.org\/10.1002\/9780470649848."},{"key":"3560_CR16","doi-asserted-by":"publisher","first-page":"3640","DOI":"10.3390\/ijms15033640","volume":"15","author":"P Gentile","year":"2014","unstructured":"Gentile P, Chiono V, Carmagnola I, Hatton P. An overview of poly(lactic-co-glycolic) acid (PLGA)-based biomaterials for bone tissue engineering. IJMS. 2014;15:3640\u201359.","journal-title":"IJMS"},{"key":"3560_CR17","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1007\/s13346-022-01228-0","volume":"13","author":"SR Abulateefeh","year":"2023","unstructured":"Abulateefeh SR. Long-acting injectable PLGA\/PLA depots for leuprolide acetate: successful translation from bench to clinic. Drug Deliv Transl Res. 2023;13:520\u201330.","journal-title":"Drug Deliv Transl Res"},{"key":"3560_CR18","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.healun.2023.01.018","volume":"42","author":"X Qu","year":"2023","unstructured":"Qu X, Li J, Liu L, Zhang J, Hua Y, Suzuki K, et al. ONO-1301 enhances post-transplantation survival of human induced pluripotent stem cell-derived cardiac tissue sheet by promoting angiogenesis. J Heart Lung Transplant. 2023;42:716\u201329.","journal-title":"J Heart Lung Transplant"},{"key":"3560_CR19","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1016\/j.stemcr.2017.09.007","volume":"9","author":"J Li","year":"2017","unstructured":"Li J, Minami I, Shiozaki M, Yu L, Yajima S, Miyagawa S, et al. Human pluripotent stem cell-derived cardiac tissue-like constructs for repairing the infarcted myocardium. Stem Cell Rep. 2017;9:1546\u201359.","journal-title":"Stem Cell Rep"},{"key":"3560_CR20","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.healun.2021.04.010","volume":"40","author":"K Suzuki","year":"2021","unstructured":"Suzuki K, Miyagawa S, Liu L, Kawamura T, Li J, Qu X, et al. Therapeutic efficacy of large aligned cardiac tissue derived from induced pluripotent stem cell in a porcine ischemic cardiomyopathy model. J Heart Lung Transplant. 2021;40:767\u201377.","journal-title":"J Heart Lung Transplant"},{"key":"3560_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0245571","volume":"16","author":"J Yokoyama","year":"2021","unstructured":"Yokoyama J, Miyagawa S, Akagi T, Akashi M, Sawa Y. Human induced pluripotent stem cell-derived three-dimensional cardiomyocyte tissues ameliorate the rat ischemic myocardium by remodeling the extracellular matrix and cardiac protein phenotype. PLoS ONE. 2021;16: e0245571.","journal-title":"PLoS ONE"},{"issue":"22","key":"3560_CR22","first-page":"00500","volume":"S1525\u20130016","author":"X Ai","year":"2022","unstructured":"Ai X, Yan B, Witman N, Gong Y, Yang L, Tan Y, et al. Transient secretion of VEGF protein from transplanted hiPSC-CMs enhances engraftment and improves rat heart function post MI. Mol Ther. 2022;S1525\u20130016(22):00500\u20137.","journal-title":"Mol Ther"},{"key":"3560_CR23","doi-asserted-by":"publisher","first-page":"12697","DOI":"10.3390\/ijms232012697","volume":"23","author":"J Zhang","year":"2022","unstructured":"Zhang J, Qu X, Li J, Harada A, Hua Y, Yoshida N, et al. Tissue sheet engineered using human umbilical cord-derived mesenchymal stem cells improves diabetic wound healing. Int J Mol Sci. 2022;23:12697.","journal-title":"Int J Mol Sci"},{"key":"3560_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2022.174994","volume":"925","author":"Y Wu","year":"2022","unstructured":"Wu Y, Zhang H, Wang S, Li L, Wang R, Jiang S. Human umbilical cord-derived stem cell sheets improve left ventricular function in rat models of ischemic heart failure. Eur J Pharmacol. 2022;925: 174994.","journal-title":"Eur J Pharmacol"},{"key":"3560_CR25","doi-asserted-by":"publisher","first-page":"e261","DOI":"10.1016\/j.jtcvs.2020.04.150","volume":"163","author":"N Kashiyama","year":"2022","unstructured":"Kashiyama N, Kormos RL, Matsumura Y, D\u2019Amore A, Miyagawa S, Sawa Y, et al. Adipose-derived stem cell sheet under an elastic patch improves cardiac function in rats after myocardial infarction. J Thorac Cardiovasc Surg. 2022;163:e261\u201372.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"3560_CR26","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.jacc.2011.09.065","volume":"59","author":"JH Houtgraaf","year":"2012","unstructured":"Houtgraaf JH, den Dekker WK, van Dalen BM, Springeling T, de Jong R, van Geuns RJ, et al. First experience in humans using adipose tissue-derived regenerative cells in the treatment of patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2012;59:539\u201340.","journal-title":"J Am Coll Cardiol"},{"key":"3560_CR27","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/nbt1117","volume":"23","author":"MA Laflamme","year":"2005","unstructured":"Laflamme MA, Murry CE. Regenerating the heart. Nat Biotechnol. 2005;23:845\u201356.","journal-title":"Nat Biotechnol"},{"key":"3560_CR28","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.jacc.2007.11.040","volume":"51","author":"J-Y Hahn","year":"2008","unstructured":"Hahn J-Y, Cho H-J, Kang H-J, Kim T-S, Kim M-H, Chung J-H, et al. Pre-treatment of mesenchymal stem cells with a combination of growth factors enhances gap junction formation, cytoprotective effect on cardiomyocytes, and therapeutic efficacy for myocardial infarction. J Am Coll Cardiol. 2008;51:933\u201343.","journal-title":"J Am Coll Cardiol"},{"key":"3560_CR29","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13287-022-02736-z","volume":"13","author":"Y Xiong","year":"2022","unstructured":"Xiong Y, Tang R, Xu J, Jiang W, Gong Z, Zhang L, et al. Sequential transplantation of exosomes and mesenchymal stem cells pretreated with a combination of hypoxia and Tongxinluo efficiently facilitates cardiac repair. Stem Cell Res Ther. 2022;13:63.","journal-title":"Stem Cell Res Ther"},{"key":"3560_CR30","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s40005-019-00439-x","volume":"49","author":"EM Elmowafy","year":"2019","unstructured":"Elmowafy EM, Tiboni M, Soliman ME. Biocompatibility, biodegradation and biomedical applications of poly(lactic acid)\/poly(lactic-co-glycolic acid) micro and nanoparticles. J Pharm Investig. 2019;49:347\u201380.","journal-title":"J Pharm Investig"},{"key":"3560_CR31","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1021\/mp300559v","volume":"10","author":"AK Mohammad","year":"2013","unstructured":"Mohammad AK, Reineke JJ. Quantitative detection of PLGA nanoparticle degradation in tissues following intravenous administration. Mol Pharm. 2013;10:2183\u20139.","journal-title":"Mol Pharm"},{"key":"3560_CR32","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1007\/s10856-008-3672-2","volume":"20","author":"X Xu","year":"2009","unstructured":"Xu X, Liu T, Liu S, Zhang K, Shen Z, Li Y, et al. Feasibility of biodegradable PLGA common bile duct stents: an in vitro and in vivo study. J Mater Sci Mater Med. 2009;20:1167\u201373.","journal-title":"J Mater Sci Mater Med"},{"key":"3560_CR33","doi-asserted-by":"publisher","first-page":"151","DOI":"10.4070\/kcj.2016.0207","volume":"47","author":"HJ Joo","year":"2017","unstructured":"Joo HJ, Kim J-H, Hong SJ. Adipose tissue-derived stem cells for myocardial regeneration. Korean Circ J. 2017;47:151\u20139.","journal-title":"Korean Circ J"},{"key":"3560_CR34","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.reth.2019.01.002","volume":"11","author":"M Nakao","year":"2019","unstructured":"Nakao M, Inanaga D, Nagase K, Kanazawa H. Characteristic differences of cell sheets composed of mesenchymal stem cells with different tissue origins. Regen Ther. 2019;11:34\u201340.","journal-title":"Regen Ther"},{"key":"3560_CR35","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/nm0405-367","volume":"11","author":"M Gnecchi","year":"2005","unstructured":"Gnecchi M, He H, Liang OD, Melo LG, Morello F, Mu H, et al. Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat Med. 2005;11:367\u20138.","journal-title":"Nat Med"},{"key":"3560_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/632972","volume":"2013","author":"N Haque","year":"2013","unstructured":"Haque N, Rahman MT, Abu Kasim NH, Alabsi AM. Hypoxic culture conditions as a solution for mesenchymal stem cell based regenerative therapy. Sci World J. 2013;2013:1\u201312.","journal-title":"Sci World J"},{"key":"3560_CR37","doi-asserted-by":"publisher","first-page":"141","DOI":"10.15171\/apb.2015.021","volume":"5","author":"M Ejtehadifar","year":"2015","unstructured":"Ejtehadifar M, Shamsasenjan K, Movassaghpour A, Akbarzadehlaleh P, Dehdilani N, Abbasi P, et al. The effect of hypoxia on mesenchymal stem cell biology. Adv Pharm Bull. 2015;5:141\u20139.","journal-title":"Adv Pharm Bull"},{"key":"3560_CR38","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s10565-019-09504-5","volume":"36","author":"L Yan","year":"2020","unstructured":"Yan L, Wu X. Exosomes produced from 3D cultures of umbilical cord mesenchymal stem cells in a hollow-fiber bioreactor show improved osteochondral regeneration activity. Cell Biol Toxicol. 2020;36:165\u201378.","journal-title":"Cell Biol Toxicol"},{"key":"3560_CR39","doi-asserted-by":"publisher","first-page":"7486279","DOI":"10.1155\/2019\/7486279","volume":"2019","author":"V Miceli","year":"2019","unstructured":"Miceli V, Pampalone M, Vella S, Carreca AP, Amico G, Conaldi PG. Comparison of immunosuppressive and angiogenic properties of human amnion-derived mesenchymal stem cells between 2D and 3D culture systems. Stem Cells Int. 2019;2019:7486279.","journal-title":"Stem Cells Int"},{"key":"3560_CR40","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/s41420-022-01235-7","volume":"8","author":"L Shao","year":"2022","unstructured":"Shao L, Shen Y, Ren C, Kobayashi S, Asahara T, Yang J. Inflammation in myocardial infarction: roles of mesenchymal stem cells and their secretome. Cell Death Discov. 2022;8:452.","journal-title":"Cell Death Discov"},{"key":"3560_CR41","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3389\/fcvm.2019.00140","volume":"6","author":"A Hanna","year":"2019","unstructured":"Hanna A, Frangogiannis NG. The role of the TGF-\u03b2 superfamily in myocardial infarction. Front Cardiovasc Med. 2019;6:140.","journal-title":"Front Cardiovasc Med"},{"key":"3560_CR42","doi-asserted-by":"publisher","first-page":"5558","DOI":"10.1016\/j.biomaterials.2011.04.031","volume":"32","author":"W-Y Lee","year":"2011","unstructured":"Lee W-Y, Wei H-J, Lin W-W, Yeh Y-C, Hwang S-M, Wang J-J, et al. Enhancement of cell retention and functional benefits in myocardial infarction using human amniotic-fluid stem-cell bodies enriched with endogenous ECM. Biomaterials. 2011;32:5558\u201367.","journal-title":"Biomaterials"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-023-03560-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-023-03560-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-023-03560-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,20]],"date-time":"2023-12-20T17:05:06Z","timestamp":1703091906000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-023-03560-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,20]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3560"],"URL":"https:\/\/doi.org\/10.1186\/s13287-023-03560-9","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,20]]},"assertion":[{"value":"1 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures and protocols involving animals were approved by the ethics committee of Osaka University (approval number: 01-062-000, approval date: 2022-03-01, name of approval project: Investigation of new therapeutic effects in ischemic heart disease model animals by tissue transplantation) and were performed according to the committee\u2019s guidelines. In addition, reporting of the animal experiments were followed in accordance with ARRIVE (Animal Research: Reporting of In Vivo Experiments) guidelines ().","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing nonfinancial interests to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"380"}}